West Pharmaceutical Services filed a 10-Q (Quarterly Report) with the SEC. — Filed Jul 23, 2026 · period ended Jun 30, 2026 · accession 0000105770-26-000099.
Item 2.02 Results of Operations and Financial Condition · Item 7.01 Regulation FD Disclosure · Item 9.01 Financial…
Item 1.05 Material Cybersecurity Incident · Item 9.01 Financial Statements and Exhibits — Filed May 20, 2026 · event…
Item 1.05 Material Cybersecurity Incident · Item 7.01 Regulation FD Disclosure · Item 9.01 Financial Statements and…
Item 1.01 Entry into a Material Definitive Agreement · Item 9.01 Financial Statements and Exhibits — Filed Jul 14, 2026…
Item 5.02 Departure or Election of Directors and Officers · Item 7.01 Regulation FD Disclosure · Item 9.01 Financial…